Absci (ABSI) Soars 10.69% as Investors Back Strategic Growth Plan
Absci (ABSI) jumps 10.69% as investors rally behind its biotech strategy, hitting $9.37 and outpacing peers—discover why the market sees growth potential.
2 minutes to read
ABSCI CORP
Absci Stock Soars 10.7% as Investors Back Synthetic‑Biology Momentum
Absci’s stock jumps 10.69% as investors rally behind its synthetic‑biology platform, driving a new $1.6 B market cap and fresh biopharma insight.
2 minutes to read
Absci (ABSI) Gains 6.21% on Nasdaq, Signals Strong Momentum in Synthetic‑Biology
Absci’s shares jump 6.21% to $9.88, driven by strong liquidity and a supportive 200‑day SMA. Discover why the biotech platform is outpacing peers and what’s next for its growth prospects.
2 minutes to read